Isolation and characterization of CD105+/CD90+ subpopulation in breast cancer MDA-MB-231 cell line

International Journal of Clinical and Experimental Pathology

Volumn 8, Issue 5, 2015, Pages 5105-5112

  Wang, Xueliang ^a   Liu, Yunjiang ^a   Zhou, Kaixuan ^a   Zhang, Geng ^a   Wang, Feifei ^a   Ren, Jingwen ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

Breast neoplasm; Cancer stem cell; CD105; CD90; Epithelial mesenchymal transition; Mesenchymal stem cells

Indexed keywords

CELL SURFACE RECEPTOR; ENDOGLIN; ENG PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; THY 1 ANTIGEN; TUMOR MARKER;

BREAST TUMOR; CANCER STEM CELL; CELL ADHESION; CELL CYCLE; CELL MOTION; CELL PROLIFERATION; CELL SEPARATION; COMPARATIVE STUDY; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MESENCHYMAL STROMA CELL; METABOLISM; PATHOLOGY; PHENOTYPE; PROCEDURES; TIME FACTOR; TUMOR CELL LINE;

ANTIGENS, CD; ANTIGENS, THY-1; BIOMARKERS, TUMOR; BREAST NEOPLASMS; CELL ADHESION; CELL CYCLE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SEPARATION; ENDOGLIN; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MESENCHYMAL STROMAL CELLS; NEOPLASTIC STEM CELLS; PHENOTYPE; RECEPTORS, CELL SURFACE; TIME FACTORS;

EID: 84937776345     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D and Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cyto-therapy 2006; 8: 315-317.
2. Nassiri F, Cusimano MD, Scheithauer BW, Rotondo F, Fazio A, Yousef GM, Syro LV, Kovacs K and Lloyd RV. Endoglin (CD105): a review of its role in angiogenesis and tumor diagnosis, progression and therapy. Anticancer Res 2011; 31: 2283-2290.
3. Saroufim A, Messai Y, Hasmim M, Rioux N, Iacovelli R, Verhoest G, Bensalah K, Patard JJ, Albiges L, Azzarone B, Escudier B and Chouaib S. Tumoral CD105 is a novel independent prognostic marker for prognosis in clear-cell renal cell carcinoma. Br J Cancer 2014; 110: 1778-1784.
4. Davidson B, Stavnes HT, Forsund M, Berner A and Staff AC. CD105 (Endoglin) expression in breast carcinoma effusions is a marker of poor survival. Breast 2010; 19: 493-498.
5. Yang ZF, Ho DW, Ng MN, Lau CK, Yu WC, Ngai P, Chu PW, Lam CT, Poon RT and Fan ST. Significance of CD90+ cancer stem cells in human liver cancer. Cancer Cell 2008; 13: 153-166.
6. Thiery JP, Acloque H, Huang RY and Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell 2009; 139: 871-890.
7. Geradts J, de Herreros AG, Su Z, Burchette J, Broadwater G and Bachelder RE. Nuclear Snail1 and nuclear ZEB1 protein expression in invasive and intraductal human breast carcinomas. Hum Pathol 2011; 42: 1125-1131.
8. Morel AP, Hinkal GW, Thomas C, Fauvet F, Courtois-Cox S, Wierinckx A, Devouassoux-Shisheboran M, Treilleux I, Tissier A, Gras B, Pourchet J, Puisieux I, Browne GJ, Spicer DB, Lachuer J, Ansieau S and Puisieux A. EMT inducers catalyze malignant transformation of mammary epithelial cells and drive tumorigenesis towards claudin-low tumors in transgenic mice. PLoS Genet 2012; 8: e1002723.
9. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, Campbell LL, Polyak K, Brisken C, Yang J and Weinberg RA. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008; 133: 704-715.
10. Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Kenney S and Boyd MR. New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 1990; 82: 1107-1112.
11. Jayat C and Ratinaud MH. Cell cycle analysis by flow cytometry: principles and applications. Biol Cell 1993; 78: 15-25.
12. Nishii T, Yashiro M, Shinto O, Sawada T, Ohira M and Hirakawa K. Cancer stem cell-like SP cells have a high adhesion ability to the peritoneum in gastric carcinoma. Cancer Sci 2009; 100: 1397-1402.
13. Reya T, Morrison SJ, Clarke MF and Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 2001; 414: 105-111.
14. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ and Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 2003; 100: 3983-3988.
15. le Viseur C, Hotfilder M, Bomken S, Wilson K, Rottgers S, Schrauder A, Rosemann A, Irving J, Stam RW, Shultz LD, Harbott J, Jurgens H, Schrappe M, Pieters R and Vormoor J. In childhood acute lymphoblastic leukemia, blasts at different stages of immunophenotypic maturation have stem cell properties. Cancer Cell 2008; 14: 47-58.
16. Yamazaki H, Nishida H, Iwata S, Dang NH and Morimoto C. CD90 and CD110 correlate with cancer stem cell potentials in human T-acute lymphoblastic leukemia cells. Biochem Bio-phys Res Commun 2009; 383: 172-177.
17. Ali AM, Ueno T, Tanaka S, Takada M, Ishiguro H, Abdellah AZ and Toi M. Determining circulating endothelial cells using CellSearch system during preoperative systemic chemotherapy in breast cancer patients. Eur J Cancer 2011; 47: 2265-2272.
18. Lobba AR, Forni MF, Carreira AC and Sogayar MC. Differential expression of CD90 and CD14 stem cell markers in malignant breast cancer cell lines. Cytometry A 2012; 81: 1084-1091.
19. Moore N and Lyle S. Quiescent, slow-cycling stem cell populations in cancer: a review of the evidence and discussion of significance. J Oncol 2011; 2011.
20. Dean M, Fojo T and Bates S. Tumour stem cells and drug resistance. Nat Rev Cancer 2005; 5: 275-284.
21. Tadbir AA, Pardis S, Ashkavandi ZJ, Najvani AD, Ashraf MJ, Taheri A, Zadeh MA and Sardari Y. Expression of Ki67 and CD105 as proliferation and angiogenesis markers in salivary gland tumors. Asian Pac J Cancer Prev 2012; 13: 5155-5159.
22. Kalluri R and Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest 2009; 119: 1420-1428.
23. Ben-Porath I, Thomson MW, Carey VJ, Ge R, Bell GW, Regev A and Weinberg RA. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet 2008; 40: 499-507.
24. Zhu QC, Gao RY, Wu W and Qin HL. Epithelial-mesenchymal transition and its role in the pathogenesis of colorectal cancer. Asian Pac J Cancer Prev 2013; 14: 2689-2698.